One-third of target group now vaccinated against monkeypox 10,440 monkeypox vaccinations have already been administered in the Netherlands in the last few weeks. That represents about one-third of the target group currently eligible to get the vaccine against monkeypox. Science Photo Library / ANP
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
National Heatwave Plan no longer in operation as of 17 August 2022 As of Wednesday, 17 August 2022, the National Heatwave Plan is no longer in operation. Although the period of persistent heat is over, temperatures will remain high over the coming days.
National Heatwave Plan to be activated on 10 August After consulting the Royal Netherlands Meteorological Institute (KNMI), RIVM has decided to activate the National Heatwave Plan in all Dutch provinces as of 10 August 2022.
No further spread of polio virus after contamination employee The employee of a Dutch vaccine manufacturer, who was infected with the polio virus in early April, is no longer carrying the virus.
HPV vaccination not only protects against cervical cancer HPV vaccination against cervical cancer also appears to protect against other forms of cancer that can be caused by HPV.
Blood analysis local residents confirms longtime exposure to PFOA The results of blood analysis show that measured blood values correspond well with the calculated values in an earlier study in 2016 on the emission of perfluorooctanoic acid (PFOA) by DuPont/Chemo
More knowledge required about environmental effect of GenX More knowledge is required about the extent to which GenX substances accumulate in fish.
Meningococcal immunisation recommendations re-examined Meningococcal disease is a very serious infectious disease that can cause meningitis or blood poisoning. Children are immunised against meningococcal serogroup C at 14 months.
Employee vaccine manufacturer infected with polio virus Early April, a sealed room at a vaccine manufacturer was the site of an incident. Two employees were exposed to the polio virus.